How to Talk to Your Doctor About GLP-1 Medications on Medicare

Asking your doctor about a weight loss medication can feel uncomfortable — especially if weight has never come up directly in your appointments before. Many Medicare beneficiaries know they want to explore GLP-1 medications like Wegovy or Zepbound but are unsure how to start the conversation, what their doctor needs to hear, or how the prior authorization process actually works. This guide walks you through exactly how to bring it up, what to say, what to ask, and how to make sure the appointment leads to a clear next step.

Why this conversation can feel hard

Weight is personal. Many seniors have spent decades hearing that weight loss is simply about willpower, diet, and exercise — and may feel embarrassed or defensive about asking for medication. Others worry their doctor will judge them or dismiss the request.

The reality in 2026 is different. The medical community now recognizes obesity as a chronic, treatable condition — not a character flaw. GLP-1 medications have been validated in large clinical trials and endorsed by major medical organizations. Most primary care physicians are familiar with them, and many are actively looking for the right patients to prescribe them to. Your doctor is far more likely to be supportive than dismissive.

What to say to start the conversation

You do not need a rehearsed speech. A direct, simple opening works best. Here are three approaches that have worked well for other patients:

The direct approach

"I have been reading about GLP-1 medications for weight management, and I understand Medicare may start covering them in July through the Bridge program. I would like to find out whether I might be a candidate."

The health-focused approach

"My weight has been affecting my [blood pressure / joints / energy / sleep / diabetes risk] for a while now. I have seen that there are new medications that can help with sustained weight loss, and I would like to talk about whether one of them makes sense for me."

The coverage-focused approach

"I heard that Medicare Part D will be covering weight loss medications starting in July. Can you help me understand whether I qualify, and what we would need to do to apply?"

All three of these are clear, respectful, and give your doctor a concrete starting point. You do not need to justify yourself beyond stating your interest.

Questions to ask your doctor during the appointment

Once the conversation is open, these questions will help you get the specific information you need:

• Based on my BMI and health history, do I meet the eligibility criteria for the Medicare GLP-1 Bridge program?
• Which GLP-1 medication would you recommend for me — and why that one over the others?
• Are there any medications I currently take that could interact with a GLP-1?
• What side effects should I expect in the first month, and when should I call you about them?
• Will you handle the prior authorization submission, or do I need to do anything on my end?
• How long does the prior authorization typically take to get approved?
• Do I need any lab work done before we can submit the paperwork?
• How often will I need follow-up appointments once I start?
• Do you recommend injectable or oral — and what are the practical differences?

What your doctor needs from you

To evaluate your eligibility and submit the prior authorization, your doctor will need specific information. Having this ready saves time and reduces the chance of a follow-up appointment before anything can move forward:

• Your Medicare Part D plan card and plan name.
• A complete list of current medications, including dosages and over-the-counter supplements.
• Recent lab results if available — A1C, fasting glucose, blood pressure, lipid panel.
• A list of weight-related health conditions you have been diagnosed with (hypertension, pre-diabetes, sleep apnea, PCOS, cardiovascular disease, osteoarthritis).
• A summary of past weight management efforts — diet programs, gym memberships, nutritionist visits, bariatric surgery consultations.
• Your current height and weight (your doctor will confirm at the visit, but knowing ahead of time helps).

How prior authorization works

Prior authorization is the step where your doctor requests approval from the Medicare Bridge program before the prescription can be filled. Here is how it typically works:

• Your doctor fills out a prior authorization form that includes your BMI, qualifying health conditions, the specific medication being prescribed, and supporting documentation.
• The form is submitted to Humana, which serves as the central processor for the Bridge program regardless of which Part D plan you are enrolled in.
• Humana reviews the submission and issues a decision — typically within 72 hours for standard requests.
• If approved, your doctor sends the prescription to a participating retail pharmacy.
• If denied, your doctor can resubmit with additional documentation or file an appeal.

You do not need to contact Humana yourself. The entire process is managed between your doctor and the central processor. Your role is to provide the information your doctor needs to make the strongest possible submission.

What if your doctor says no

Not every doctor will be familiar with the Bridge program, and not every doctor prescribes GLP-1 medications. If your doctor declines or seems unsure, here are your options:

• Ask why. If there is a specific clinical reason (drug interaction, contraindication, a health condition that makes GLP-1s risky for you), that is important information worth understanding.
• Ask for a referral. Request a referral to an endocrinologist or an obesity medicine specialist who has experience prescribing GLP-1 medications.
• Seek a second opinion. You have the right to consult another physician. Obesity medicine specialists and endocrinologists are typically the most experienced with these medications.
• Check telehealth options. Some telehealth providers specialize in GLP-1 prescriptions and can handle the prior authorization process. Confirm they can work with Medicare Part D before scheduling.

A doctor declining to prescribe does not mean you do not qualify. It may simply mean that particular provider is not the right fit for this specific treatment.

What happens after the appointment

If your doctor agrees to move forward, the typical timeline looks like this:

• Day 1: Your appointment. Doctor evaluates eligibility and submits prior authorization.
• Days 2 to 4: Humana processes the prior authorization (standard turnaround is approximately 72 hours).
• Day 4 to 7: If approved, your prescription is sent to the pharmacy. You pick it up and pay your $50 copay.
• Week 1: You take your first dose. Side effects — particularly mild nausea and reduced appetite — are most common in the first week.
• Weeks 2 to 4: Your body adjusts. Most side effects ease during this period.

During the first month, tracking your daily experience is the single most useful thing you can do. What you eat, how much water you drink, how you feel after your injection, and when symptoms are worst — these patterns help your doctor make better decisions at your follow-up appointment.

CairnSpace offers a free daily check-in and meal logger built specifically for people on GLP-1 medications. It takes about a minute each day and builds a clear record you can share with your prescriber. No cost, no ads, and your data is never shared or sold.

A note for adult children helping a parent

If you are researching this on behalf of a parent or older family member, the most helpful thing you can do is help them prepare for the appointment. Print the question list above, help them gather their medication list and lab results, and if possible, offer to attend the appointment with them. The medical terminology and insurance process can be overwhelming, and having a second person in the room to take notes makes a real difference.

Sources

Information in this article is based on publicly available sources, including:

Related Articles

• The Medicare GLP-1 Bridge Program: What It Is, Who Qualifies, and How to Enroll
• GLP-1 Side Effects Seniors Should Know Before Starting
• A Week-by-Week Checklist for Your First Month on a GLP-1 — Medicare Edition

• Centers for Medicare and Medicaid Services (CMS) — Medicare Part D coverage policies and Bridge program guidelines.
• FDA prescribing information for Wegovy (semaglutide), Zepbound (tirzepatide), and related GLP-1 medications.
• American Medical Association guidelines on obesity treatment and patient-physician communication.
• Medicare.gov — beneficiary resources on prescription drug coverage, prior authorization, and appeals.

This article is general education only. Always follow the guidance of your prescribing healthcare provider and confirm coverage details directly with your Medicare Part D plan.